Antidepression of Xingpijieyu formula targets gut microbiota derived from depressive disorder.
Yannan LiLixuan YangJunnan LiWei GaoZhonghui ZhaoKaiqiang DongWenzhe DuanBaoan DaiRong-Juan GuoPublished in: CNS neuroscience & therapeutics (2022)
XPJYF treatment targets inflammation, activation, and glycometabolim in astrocyte via gut microbiota modulation, thereby improve animal behaviors, HPA axis dysfunction, and neurotransmitter synthesis in depression rats.